Digital Pathology in the Setting of COVID-19

Rajesh C. Dash, Professor of Pathology and Medical Director LIS

Leica Biosystems Knowledge Pathway content is subject to the Leica Biosystems website terms of use, available at: Legal Notice. The content, including webinars, training presentations and related materials is intended to provide general information regarding particular subjects of interest to health care professionals and is not intended to be, and should not be construed as, medical, regulatory or legal advice. The views and opinions expressed in any third-party content reflect the personal views and opinions of the speaker(s)/author(s) and do not necessarily represent or reflect the views or opinions of Leica Biosystems, its employees or agents. Any links contained in the content which provides access to third party resources or content is provided for convenience only.

For the use of any product, the applicable product documentation, including information guides, inserts and operation manuals should be consulted.

Copyright © 2023 Leica Biosystems division of Leica Microsystems, Inc. and its Leica Biosystems affiliates. All rights reserved. LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.

About the presenter

Rajesh C. Dash, Professor of Pathology and Medical Director LIS

Dr. Dash is a board certified pathologist recognized worldwide for his laboratory informatics expertise. He is co-chair of Integrating the Healthcare Enterprise (IHE) Anatomic Pathology and active on a number of national committees including serving on a number of technology related committees for the College of American Pathologists.

He is director for laboratory informatics for Duke University Health System in Durham NC. Dr. Dash has over 26 years of diverse experience in Pathology, with a focus on breast cancer diagnostics, cytopathology, and laboratory informatics.  Dr. Dash is American Board of Pathology certified in Anatomic & Clinical Pathology, Cytopathology and Clinical Informatics. 

想让我们报道你的作品吗？
我们正在寻找更多优秀作者，请提交作品，我们将与您联系！
提交您的作品
喜欢你看到的内容吗？
发送更多内容至您的邮箱，可随时取消订阅。
立即订阅!